Part: 12         Session: 123456789101112131415161718192021222324252627282930313233343536         Page 182183184185186187188189190191192193194195196196197198199200201202203204205206207208209210211212 of 1143

In young men, between the ages of 35 and 50, they showed that they deaths were reduced by 50 percent. Jesse shows more than that, about 60 to 68 percent. Jesse shows about the same figure in younger-aged groups, like 35--55, and she has also tried it in males over 55 and her overall death-reduction rate in her first published study--published in June of '62--showed a total reduction of about 50 percent.

Now, this is not the final answer to arteriosclerosis but it is a wedge in, and it was financed by the Public Health Service and by the Lasker Foundation. The Heart Institute gave most of the money to Katz and Stammler and I gave over the years about $700,000 to the University of Southern California group and the rest of their funds came from the Heart Institute. This is the beginning of a new effort to reduce the death rate from arteriosclerosis, other than the use of anticoagulants.

What about the research in cholesterol?

We have shown that cholesterol drops in the case four milligrams per day, but Jessie figures are just as good, a lower dosage, it's non-feminizing; it's only a milligram and a quarter a day but at that dosage cholesterol levels don't drop. So, there's some other element that influencing the death rate in addition to cholesterol, and that's another thing that needs to be unravelled. She doesn't say cholesterol has nothing